Key result
LPS treatment increased total nitric oxide synthase activity 2.4-fold in the hemocytes of the freshwater snail Viviparus ater.
This study provides the first biochemical demonstration of nitric oxide synthase activity in molluscan hemocytes.
Answers are grounded in this paper and cite their sources.
First NOS demonstration in molluscan hemocytes; hypothesis-generating for invertebrate immunity and leaves open translation to vertebrates.
The hemocytes of the freshwater snail Viviparus ater have nitric oxide synthase (NOS) activity, as demonstrated by [3H]citrulline and nitrite + nitrate formation. The enzyme is NADPH dependent and is competitively inhibited by the mammalian NOS inhibitor NG-monomethyl-L-arginine (Ki = 4.7 microM). The Km for L-arginine is 2.5 microM. 70% of the total activity is observed at very low free Ca2+ concentration (3 nM). LPS treatment increased total NOS activity 2.4 fold. The activity is partly present in the non-soluble fraction of hemocytes (24% and 8% in non-stimulated and LPS-stimulated snails, respectively). An antiserum to the C-terminal synthetic pentadecapeptide of the rat cerebellar NOS inhibited the enzyme activity in a concentration-dependent manner. This is the first biochemical demonstration of the existence of NOS activity in molluscan hemocytes, the cells responsible for defence mechanisms.
No takes yet. Share an insight, caveat, or question.
Conte et al. (1995) studied Freshwater snail Viviparus ater hemocytes. LPS treatment vs. Non-stimulated snails was evaluated on Nitric oxide synthase (NOS) activity. LPS treatment increased total nitric oxide synthase activity 2.4-fold in the hemocytes of the freshwater snail Viviparus ater.
Synapse has enriched 10 related papers. Consider them for comparative context: